On-the-road driving ability: An overview of the differences between first-, second-, and third-generation antihistamines

被引:0
|
作者
Verster, JC [1 ]
Volkerts, ER [1 ]
机构
[1] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3508 TC Utrecht, Netherlands
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S271 / S271
页数:1
相关论文
共 50 条
  • [41] Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit?
    Canet, Jim
    Cony-Makhoul, Pascale
    Orazio, Sebastien
    Cornet, Edouard
    Troussard, Xavier
    Maynadie, Marc
    Etienne, Gabriel
    Monnereau, Alain
    CANCER MEDICINE, 2021, 10 (20): : 6959 - 6970
  • [42] First-line imatinib vs second- and third-generation TKIs for chronic-phase CML: a systematic review and meta-analysis
    Vener, Claudia
    Banzi, Rita
    Ambrogi, Federico
    Ferrero, Annalisa
    Saglio, Giuseppe
    Pravettoni, Gabriella
    Sant, Milena
    BLOOD ADVANCES, 2020, 4 (12) : 2723 - 2735
  • [43] Differences in Self-Regulation for Online Learning Between First- and Second-Generation College Students
    Peter E. Williams
    Chan M. Hellman
    Research in Higher Education, 2004, 45 : 71 - 82
  • [44] Differences in self-regulation for Online learning between first- and second-generation college students
    Williams, PE
    Hellman, CM
    RESEARCH IN HIGHER EDUCATION, 2004, 45 (01) : 71 - 82
  • [45] Search for pair-produced scalar and vector leptoquarks decaying into third-generation quarks and first- or second-generation leptons in pp collisions with the ATLAS detector
    Aad, G.
    Abbott, B.
    Abbott, D. C.
    Abeling, K.
    Abidi, S. H.
    Aboulhorma, A.
    Abramowicz, H.
    Abreu, H.
    Abulaiti, Y.
    Abusleme Hoffman, A. C.
    Acharya, B. S.
    Achkar, B.
    Adam, L.
    Adam Bourdarios, C.
    Adamczyk, L.
    Adamek, L.
    Addepalli, S. V.
    Adelman, J.
    Adiguzel, A.
    Adorni, S.
    Adye, T.
    Affolder, A. A.
    Afik, Y.
    Agaras, M. N.
    Agarwala, J.
    Aggarwal, A.
    Agheorghiesei, C.
    Aguilar-Saavedra, J. A.
    Ahmad, A.
    Ahmadov, F.
    Ahmed, W. S.
    Ai, X.
    Aielli, G.
    Aizenberg, I.
    Akbiyik, M.
    Akesson, T. P. A.
    Akimov, A. V.
    Al Khoury, K.
    Alberghi, G. L.
    Albert, J.
    Albicocco, P.
    Alconada Verzini, M. J.
    Alderweireldt, S.
    Aleksa, M.
    Aleksandrov, I. N.
    Alexa, C.
    Alexopoulos, T.
    Alfonsi, A.
    Alfonsi, F.
    Alhroob, M.
    JOURNAL OF HIGH ENERGY PHYSICS, 2023, 2023 (06)
  • [46] Search for pair-produced scalar and vector leptoquarks decaying into third-generation quarks and first- or second-generation leptons in pp collisions with the ATLAS detector
    G. Aad
    B. Abbott
    D. C. Abbott
    K. Abeling
    S. H. Abidi
    A. Aboulhorma
    H. Abramowicz
    H. Abreu
    Y. Abulaiti
    A. C. Abusleme Hoffman
    B. S. Acharya
    B. Achkar
    L. Adam
    C. Adam Bourdarios
    L. Adamczyk
    L. Adamek
    S. V. Addepalli
    J. Adelman
    A. Adiguzel
    S. Adorni
    T. Adye
    A. A. Affolder
    Y. Afik
    M. N. Agaras
    J. Agarwala
    A. Aggarwal
    C. Agheorghiesei
    J. A. Aguilar-Saavedra
    A. Ahmad
    F. Ahmadov
    W. S. Ahmed
    X. Ai
    G. Aielli
    I. Aizenberg
    M. Akbiyik
    T. P. A. Åkesson
    A. V. Akimov
    K. Al Khoury
    G. L. Alberghi
    J. Albert
    P. Albicocco
    M. J. Alconada Verzini
    S. Alderweireldt
    M. Aleksa
    I. N. Aleksandrov
    C. Alexa
    T. Alexopoulos
    A. Alfonsi
    F. Alfonsi
    M. Alhroob
    Journal of High Energy Physics, 2023
  • [47] Comparison of post-stent irregular protrusion and subsequent neointimal characteristics between second- and third-generation drug-eluting stent implantation
    Miura, Toshiya
    Sonoda, Shinjo
    Sanuki, Yoshinori
    Naka, Yutaro
    Okabe, Hiroki
    Setoyama, Koshi
    Inoue, Konosuke
    Shimizu, Akiyoshi
    Anai, Reo
    Tsuda, Yuki
    Araki, Masaru
    Otsuji, Yutaka
    JOURNAL OF CARDIOLOGY, 2020, 76 (05) : 464 - 471
  • [48] Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials
    G Ferretti
    E Bria
    D Giannarelli
    A Felici
    P Papaldo
    A Fabi
    S Di Cosimo
    E M Ruggeri
    M Milella
    M Ciccarese
    F L Cecere
    A Gelibter
    C Nuzzo
    F Cognetti
    E Terzoli
    P Carlini
    British Journal of Cancer, 2006, 94 : 1789 - 1796
  • [49] Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials
    Ferretti, G.
    Bria, E.
    Giannarelli, D.
    Felici, A.
    Papaldo, P.
    Fabi, A.
    Di Cosimo, S.
    Ruggeri, E. M.
    Milella, M.
    Ciccarese, M.
    Cecere, F. L.
    Gelibter, A.
    Nuzzo, C.
    Cognetti, F.
    Terzoli, E.
    Carlini, P.
    BRITISH JOURNAL OF CANCER, 2006, 94 (12) : 1789 - 1796
  • [50] <sans-serif>Differences between first- and second-generation autologous platelet concentrates</sans-serif>
    Calciolari, Elena
    Dourou, Marina
    Akcali, Aliye
    Donos, Nikolaos
    PERIODONTOLOGY 2000, 2025, 97 (01) : 52 - 73